Exelixis (EXEL) Operating Leases (2010 - 2026)
Exelixis (EXEL) posted quarterly Operating Leases of $169.5 million for Q2 2026, down 9.4% year-over-year from $187.1 million in Q2 2025, and down 2.02% quarter-over-quarter from $173.0 million in Q1 2026.
Exelixis (EXEL) Operating Leases (2010 - 2026) Analysis & Trends
Exelixis' Operating Leases history runs 15 years deep, the most recent figure standing at $169.5 million for Q2 2026.
- In Q2 2026, Operating Leases fell 9.4% year-over-year to $169.5 million; the TTM figure through Apr 2026 stood at $169.5 million (down 9.4% YoY), while the FY2026 annual figure was $173.0 million, down 19.83% from the prior year.
- Operating Leases for Q2 2026 stood at $169.5 million, down from $173.0 million in the prior quarter.
- The five-year high for Operating Leases was $215.8 million in Q1 2025, with the low at $50.6 million in Q2 2022.
- The 5-year median for Operating Leases is $187.1 million (2025), against an average of $180.2 million.
- The sharpest annual moves came in 2022 and 2026: Operating Leases jumped 305.35% in 2022, then declined 19.83% in 2026.
- Exelixis' Operating Leases stood at $207.8 million in 2022, then gained by 3.77% to $215.7 million in 2023, then dropped by 9.84% to $194.4 million in 2024, then retreated by 9.25% to $176.5 million in 2025, then retreated by 3.92% to $169.5 million in 2026.
- Business Quant data shows EXEL's Operating Leases at $169.5 million in Q2 2026, $173.0 million in Q1 2026, and $176.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Exelixis | 12.75 Bn | 11.91 Bn | 608.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 165.93 Mn |
| Apr 3, 2026 | 169.54 Mn |
| Jan 2, 2026 | 173.04 Mn |
| Oct 3, 2025 | 176.46 Mn |
| Jul 4, 2025 | 179.84 Mn |
| Apr 4, 2025 | 187.13 Mn |
| Jan 3, 2025 | 215.83 Mn |
| Sep 27, 2024 | 194.45 Mn |
| Jun 28, 2024 | 198.02 Mn |
| Mar 29, 2024 | 201.47 Mn |
| Dec 29, 2023 | 215.66 Mn |
| Sep 29, 2023 | 190.86 Mn |
| Jun 30, 2023 | 194.69 Mn |
| Mar 31, 2023 | 186.95 Mn |
| Dec 30, 2022 | 207.83 Mn |
| Sep 30, 2022 | 159.84 Mn |
| Jul 1, 2022 | 161.02 Mn |
| Apr 1, 2022 | 50.64 Mn |
| Dec 31, 2021 | 51.27 Mn |
| Oct 1, 2021 | 52.25 Mn |